FGFBP3 Antibody (C-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 文献引用 : 1
- 实验流程
Application ![]()
| WB, IHC-P, FC, E |
---|---|
Primary Accession | Q8TAT2 |
Other Accession | NP_689642.3 |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 27590 Da |
Antigen Region | 181-210 aa |
Gene ID | 143282 |
---|---|
Other Names | Fibroblast growth factor-binding protein 3, FGF-BP3, FGF-binding protein 3, FGFBP-3, FGFBP3, C10orf13 |
Target/Specificity | This FGFBP3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 181-210 amino acids from the C-terminal region of human FGFBP3. |
Dilution | WB~~1:1000 IHC-P~~1:100~500 FC~~1:10~50 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | FGFBP3 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | FGFBP3 |
---|---|
Synonyms | C10orf13 |
Function | Heparin-binding protein which binds to FGF2, prevents binding of FGF2 to heparin and probably inhibits immobilization of FGF2 on extracellular matrix glycosaminoglycans, allowing its release and subsequent activation of FGFR signaling which leads to increased vascular permeability. |
Cellular Location | Secreted. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.

Application Protocols
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Zhang, W., et al. J. Biol. Chem. 283(42):28329-28337(2008)
Deloukas, P., et al. Nature 429(6990):375-381(2004)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.